GSK (LON:GSK) Given "Hold" Rating at Deutsche Bank Aktiengesellschaft

GSK (LON:GSK - Get Free Report)'s stock had its "hold" rating restated by analysts at Deutsche Bank Aktiengesellschaft in a report released on Tuesday, Marketbeat.com reports. They currently have a GBX 1,450 ($19.71) price objective on the stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 1.43% from the stock's previous close.

GSK has been the topic of a number of other reports. Shore Capital reissued a "buy" rating on shares of GSK in a research report on Wednesday, April 30th. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a report on Friday, March 28th.

GSK Trading Up 1.1%

Shares of GSK traded up GBX 15.50 ($0.21) during mid-day trading on Tuesday, hitting GBX 1,429.50 ($19.43). The company had a trading volume of 46,878,352 shares, compared to its average volume of 14,279,535. The business's 50-day simple moving average is GBX 1,438.23 and its 200-day simple moving average is GBX 1,418.71. The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64. GSK has a 1-year low of GBX 1,242.50 ($16.89) and a 1-year high of GBX 1,678.68 ($22.82). The stock has a market cap of £58.01 billion, a PE ratio of 23.09, a P/E/G ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The company reported GBX 44.90 ($0.61) earnings per share for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. Sell-side analysts forecast that GSK will post 175.980975 earnings per share for the current year.

Insider Transactions at GSK

In other news, insider Wendy Becker purchased 545 shares of the stock in a transaction dated Friday, June 20th. The stock was acquired at an average price of GBX 1,435 ($19.51) per share, for a total transaction of £7,820.75 ($10,631.80). Also, insider Jonathan Symonds bought 1,350 shares of the firm's stock in a transaction that occurred on Friday, June 20th. The stock was bought at an average price of GBX 1,435 ($19.51) per share, with a total value of £19,372.50 ($26,335.64). Over the last quarter, insiders bought 1,905 shares of company stock worth $2,732,835. Insiders own 1.61% of the company's stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.